On March 12th, the Gold Coast Convention and Exhibition Centre (GCCEC) in Queensland hosted the Southern Hemisphere's largest pharmaceutical event—the 2026 Australian Pharmacy Professional Conference & Trade Exhibition (APP Conference). This industry benchmark event, with a history spanning over three decades, gathered more than 7,500 top-tier pharmacists, industry leaders, and scholars from around the globe this year to engage in in-depth dialogues on cutting-edge advancements and emerging trends in pharmacy.
Among the more than 450 professional exhibition booths, the stand of Witsbb, an Australian infant and child nutrition brand, attracted considerable attention. It is reported that this year's APP Conference exhibition featured over 450 booths, showcasing cutting-edge global products and technologies. Witsbb drew the gaze of numerous professional visitors with its clean, professional booth design and a range of products certified by the Australian Therapeutic Goods Administration (TGA). As a member of the Complementary Medicines Australia (CMA) and a holder of the authoritative "Australian Made" certification, Witsbb's entire production process adheres to TGA pharmaceutical-grade quality management standards. From the Liquid Calcium, Vitamin AD, DHA Algae Oil Capsules, to the Grow Pro TalPlax Series...behind each flagship product lies a core focus: how to build a safe nutritional defence line for babies with sensitive constitutions.
The highlight at the booth was undoubtedly the debut of Witsbb's new product—Organic DHA Veggie softgel for Kids. Professional attendees were not focused on the packaging, but rather on its innovative formulation and rigorous evidence-based framework. It is understood that this Organic DHA holds both USDA Organic and Australian Organic certifications, featuring a one-bottle-one-code traceability system. Each softgel contains a high concentration of 120mg DHA, precisely meeting the growing global demand for "safe, pure, and precise" infant and child nutritional products.
During the APP Conference, Witsbb engaged in in-depth exchanges with top-tier global pharmacists and industry experts regarding cutting-edge trends in allergy parenting, while also seeking deeper international collaborations.
Leveraging its "Australian R&D + Global Supply" model, Witsbb's products have reached over 7.5 million families with sensitive babies worldwide. Its presence at the APP Conference signifies not only international professional recognition of the brand's scientific strength but also another practical application of its development philosophy: "shielded by science, prioritizing safety."